Literature DB >> 6608278

Experimental autoimmune damage to rat male accessory glands. II. T cell requirement in adoptive transfer of specific tissue damage.

B Pacheco-Rupil, M Depiante-Depaoli, B Casadio.   

Abstract

Experimental autoimmune vesiculo-prostatitis (EAVP) was transferred within inbred Wistar rats by a relatively small number of spleen cells obtained 30 days after immunization of donors with MAG extract in CFA and injected in the internal jugular vein of recipients. Specific tissue alterations identical to those present in the glands of the donors were observed 7 days after the transfer of the cells. The main alteration present was infiltration of mononuclear cells in the interstitium accompanied by fibrosis in more severe cases and flattening of epithelium in the ventral and dorsal prostate, seminal vesicle, and occasionally in coagulating gland. Nine out of ten recipients developed sexual accessory glandular lesions of various degrees. No histological alterations were observed in the absence of cell-mediated immune response and extensive damage was only observed in rats expressing two or more positive assays. The separation of the transferred cells into enriched population of T and B cells has proved that T lymphocytes are required for the production of the tissue lesions. Depletion of T lymphocytes by nylon wool separation and anti-rat thymocytes serum and complement completely abrogate their capacity to transfer the glandular alterations. Furthermore, specific antibody precursor cells on their own seem to be incapable to promote the antibody synthesis and to initiate the glandular damage. We conclude that T lymphocytes are required for the adoptive transfer of specific tissue damage observed in autoimmune vesiculo-prostatitis as well as for the development of a cell-mediated immune response to MAG antigens. Whether the same or distinct T-cell subsets are involved in these two effects is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6608278     DOI: 10.1111/j.1600-0897.1984.tb00281.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 0271-7352            Impact factor:   3.886


  11 in total

1.  Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

Authors:  C Wei; R A Willis; B R Tilton; R J Looney; E M Lord; R K Barth; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 2.  Mechanisms in prostatitis/chronic pelvic pain syndrome.

Authors:  Michel A Pontari; Michael R Ruggieri
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

3.  Production of reactive nitrogen intermediates (RNI) by peritoneal macrophages from rats with experimental autoimmune prostatitis (EAP).

Authors:  M A Orsilles; M Depiante-Depaoli
Journal:  Inflammation       Date:  1995-08       Impact factor: 4.092

Review 4.  The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Marco Dellabella; Giulio Milanese; Sandra Sigala; Gianluca d'Anzeo; Nicola Arrighi; Serena Bodei; Giovanni Muzzonigro
Journal:  Inflamm Res       Date:  2009-12       Impact factor: 4.575

5.  Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis.

Authors:  M Maccioni; V E Rivero; C M Riera
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 6.  Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Michel A Pontari
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 7.  Prostatitis versus pelvic pain syndrome: immunologic studies.

Authors:  Caroline Maake; Hubert John
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 8.  Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome.

Authors:  María L Breser; Florencia C Salazar; Viginia E Rivero; Rubén D Motrich
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

9.  The mediation of interleukin-17 and chemokine ligand 2 in pelvic pain of experimental autoimmune prostatitis.

Authors:  Xiaodong Liu; Shicheng Fan; Mingxing Zheng; Jianheng Chen; Jianhua Zhang; Hao Li
Journal:  Exp Ther Med       Date:  2017-05-11       Impact factor: 2.447

10.  New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.

Authors:  Shin-Jen Lin; Fu-Ju Chou; Chang-Yi Lin; Hong-Chiang Chang; Shuyuan Yeh; Chawnshang Chang
Journal:  Oncotarget       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.